|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/357 | (2006.01) |
| A61K 9/127 | (2013.01) | ||
| A61K 9/127 | (2006.01) | ||
| A61K 31/357 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 43/00 | (2006.01) |
| (11) | Number of the document | 3449921 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17789632.1 |
| Date of filing the European patent application | 2017-04-26 | |
| (97) | Date of publication of the European application | 2019-03-06 |
| (45) | Date of publication and mention of the grant of the patent | 2023-05-31 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/JP2017/016633 |
| Date | 2017-04-26 |
| (87) | Number | WO 2017/188350 |
| Date | 2017-11-02 |
| (30) | Number | Date | Country code |
| 2016091919 | 2016-04-28 | JP |
| (72) |
ASANO, Makoto , JP
MATSUI, Junji , JP
|
| (73) |
Eisai R&D Management Co., Ltd. ,
4-6-10 Koishikawa
Bunkyo-ku, Tokyo 112-8088,
JP
|
| (54) | ERIBULIN FOR INHIBITING TUMOR GROWTH |
| ERIBULIN FOR INHIBITING TUMOR GROWTH |